TAC1 and cancer: Recently, several research groups reported that one of cell essential enzymes, the sodium-potassium ATPase, could be a valid target in cancer treatment and that some of the natural compounds, from the group of CSs, are very potent inhibitors of NKA and when used at nontoxic low nanomolar concentrations, even selective for cancer cells.